IMM 20.3% 35.5¢ immutep limited

CNBC - Immunotherpay Kite Pharma CEO, page-4

  1. 25,351 Posts.
    lightbulb Created with Sketch. 1377
    Joe, all this sort of stuff came out with the Stuart Roberts meeting a couple of weeks ago....
    Stuart was talking to us in a very impromptu convivial manner.........He mentioned
    there is a very large untapped market in China where statistics are not readily accessible...
    This sort of made my ears prick up because it was not something I had ever given a thought too,
    or indeed have any reason to consider.......As I said once before Stuarts parting words
    of a couple of weeks ago were that he hadn't given up on CVAC.....
    Prima has some very influential partners in a few of their trials etc.....For a small
    company to have so many influential big pharma sniffing around, need I say more.
 
watchlist Created with Sketch. Add IMM (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.